UQ start-up research offers hope for herpes sufferers
Monday, October 24, 2011 - 08:30
in Health & Medicine
A University of Queensland (UQ) start-up company, Coridon Pty Ltd, established to commercialise Professor Ian Frazer's work in developing next generation DNA vaccines, has successfully completed pre-clinical efficacy testing of its prototype Herpes Simplex Virus 2 (HSV-2) vaccine, with outstanding results.